$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Medical drugs
Medical drugs
Medical drugs-Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Are there any special precautions for patients with diabetes mellitus?
2026-02-01 22:25:32
Check Details
Is Apelvis effective for all breast cancer patients?
2026-02-01 22:25:32
Check Details
What are the advantages of Apelix compared to other anticancer drugs?
2026-02-01 22:25:32
Check Details
New treatment options for chronic myelogenous leukemia: in-depth analysis of the differences between axitinib and ivetinib
2026-02-01 22:25:32
Check Details
What drug is Asiminib?
2026-02-01 22:25:32
Check Details
Aceminib a new option for treating chronic myelogenous leukemia
2026-02-01 22:25:32
Check Details
How to buy the drug Aceminid?
2026-02-01 22:25:32
Check Details
Guide to the best time to take Aceminid
2026-02-01 22:25:32
Check Details
Aceminib is a new option for the treatment of chronic myelogenous leukemia and its indications are explained in detail
2026-02-01 22:25:32
Check Details
Analysis of the continuous medication strategy and no fixed course of treatment for aximini in the treatment of CML
2026-02-01 22:25:32
Check Details
How toxic is Aceminid?
2026-02-01 22:25:32
Check Details
2024 Vancevit Buying Guide: Detailed explanation of channels, prices and medical insurance reimbursement
2026-02-01 22:25:32
Check Details
1
2
...
1041
1042
1043
1044
1045
1046
1047
...
2439
2440
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
FDA Approves Lytenava: First Ophthalmic Bevacizumab for Wet AMD
2
AbbVie’s TEPKINLY (epcoritamab) Plus R² Granted EU Approval for Relapsed/Refractory Follicular Lymphoma
3
Global Oncology Update: Breakthroughs in Advanced Cancer Survival and Novel Therapies
4
Phase 1 Study Progress of Ceralasertib in Combination with Durvalumab for Advanced NSCLC and HNSCC
5
Global Breakthroughs in Cancer Drugs and Advanced Treatment Technologies
6
ROS and Cancer: The Potential of Natural Antioxidants
7
SKYSCRAPER-02C Study: New Hope for Extensive-Stage Small Cell Lung Cancer Treatment
8
LPCAT3: The Key Player in MASH Progression to Hepatocellular Carcinoma
9
Breztri Aerosphere Approved by US FDA for Maintenance Treatment of Asthma in Patients Aged 12 Years and Older
10
Datopotamab Deruxtecan as First-Line Treatment for Advanced Triple-Negative Breast Cancer: Full Interpretation of the Phase III TROPION-Breast02 Trial
11
Olaparib Plus Pembrolizumab Maintenance Therapy for Metastatic Pancreatic Cancer: Findings from the POLAR Phase II Basket Trial
12
From Causes to Treatments—Exploring Medical Breakthroughs